AMP - Activated Protein Kinase (AMPK)
Search documents
SCYNEXIS (NasdaqGM:SCYX) Earnings Call Presentation
2026-03-31 12:30
Advancing innovative solutions for severe rare diseases Corporate Deck March 2026 Legal Disclaimers This presentation has been prepared by SCYNEXIS, Inc. (the "Company") solely for informational purposes. This presentation contains, and our officers and representatives may from time to time make, "forward-looking statements" within the meaning of applicable securities laws and are prospective in nature, including, but not limited to, statements regarding the Company's business strategies and goals, plans an ...